Clinical Trial Update: Study of Quizartinib in Japanese Patients With Newly Diagnosed Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

This is a Phase 1 trial evaluating quizartinib in Japanese patients with newly diagnosed acute myeloid leukemia; the study has completed and results were posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Quizartinib (Quizartinib)

Snippet

Sponsor: Daiichi Sankyo Co., Ltd. | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED | Results posted: 2021-08-19